Biopharmaceutical
Usa
Antiviral
Development
Acquire
Pharmaceuticals
M&A Advisory
Lazard
Full Credential Description
Inhibitex. United States. Announced Date 10/04/2007. Closed Date 20/09/2007. Deal value: $24m. Inhibitex to acquire FermaVir Pharmaceuticals. Industry: Inhibitex was a biopharmaceutical company focused on developing antiviral drugs.